Study Details
Testing the Drug JNT-517 in People with Phenylketonuria
(IRB#: IRB_00189870)
Phenylketonuria (PKU) is a condition in which a persons body does not break down an amino acid called phenylalanine. People with PKU must follow a special diet limiting the amount of protein they eat. This study will test a drug called JNT-517 to treat people with this disease. The study wants to see if the drug will help people with the disease and is safe. Being in the study requires attending in person visits at the study clinic with an option for a couple home visits over about 9 to 13 weeks. Participants will keep a diet diary. Medical tests will be done during the study to track the health of participants.
- All genders
- All Ages
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: All Ages
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 4 and up
- not taking pegvaliase within 4 weeks of screening for the study
- not taking sepiapterin within 2 weeks of screening for the study
Exclusion Criteria
- History of significant liver disease
Will I be paid for my time?
Yes
IRB#: IRB_00189870
PI: Ashley Andrews
Department: PEDIATRIC ADMINISTRATION
Approval Date: 2025-10-15 06:00:00
Specialties: Pediatric Genetics
I am Interested